JP Morgan Healthcare Conference, Day Three: NanoString, BD, Bio-Rad, Cepheid, Quidel, GenMark, PacBio, Adaptive Biotechnologies | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – The 32nd Annual JP Morgan Healthcare Conference continued here Wednesday with presentations from several life science tools and diagnostic firms.

The following are capsules from the presentations and breakout sessions of Nanostring, Becton Dickinson, Bio-Rad, Cepheid, Quidel, GenMark, Pacific Biosciences, and Adaptive Biotechnologies. Coverage of Danaher's presentation, in which the company discussed its acquisition plans, is available here.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.